Outlook Therapeutics (OTLK) Earnings Analysis
Outlook Therapeutics (OTLK) next reports earnings on 2026-08-13, consensus EPS -0.09 USD. Last quarter (2026-05-15) it missed with EPS -0.16 USD vs -0.12 USD est (-33.3%). It has beaten estimates in 4/8 recent quarters (50%). Trailing P/E -0.98.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does OTLK next report earnings?
| Next earnings date | 2026-08-13 |
|---|---|
| Consensus EPS estimate | -0.09 USD |
| Revenue estimate | 0.00B |
OTLK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-15 | -0.16 USD | -0.12 USD | -33.3% | Miss |
| 2026-02-17 | -0.22 USD | -0.17 USD | -29.4% | Miss |
| 2025-12-19 | -0.22 USD | -0.26 USD | +15.4% | Beat |
| 2025-08-14 | -0.44 USD | -0.42 USD | -4.8% | Miss |
| 2025-05-15 | -0.4 USD | -0.55 USD | +27.3% | Beat |
| 2025-02-14 | -0.89 USD | -0.85 USD | -4.7% | Miss |
| 2024-12-27 | -0.77 USD | -0.83 USD | +7.2% | Beat |
| 2024-08-14 | -0.83 USD | -1.06 USD | +21.7% | Beat |
Beat rate: 4/8 (50%) over reported quarters with consensus data.
OTLK valuation and analyst view
| Trailing P/E | -0.98 |
|---|---|
| Trailing EPS | -0.74486 USD |
| Price / book | -3.78 |
| Dividend yield | 0.00% |
| Market cap | 0.05B |
| Analyst consensus | Buy (7 buy / 7 hold / 0 sell) |
| Avg price target | 1 USD |
Related research pages
Frequently asked questions
When is Outlook Therapeutics (OTLK)'s next earnings date?
Outlook Therapeutics is next scheduled to report on 2026-08-13, with a consensus EPS estimate of -0.09 USD and revenue estimate of 0.00B.
Did OTLK beat earnings last quarter?
In its 2026-05-15 report, OTLK posted EPS of -0.16 USD versus a -0.12 USD estimate — a miss of 33.3%.
What is OTLK's earnings track record?
Over the last 8 reported quarters with consensus data, OTLK beat estimates 4 times (50%).
What is OTLK's current P/E ratio and EPS?
OTLK trades at a trailing P/E of -0.98 on trailing EPS of -0.7448615157143555 USD.
What do analysts rate OTLK?
Analyst consensus is "Buy" across 14 ratings (0 strong buy, 7 buy, 7 hold, 0 sell, 0 strong sell). Average 12-month price target: 1 USD.